Overview
Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)
Status:
Completed
Completed
Trial end date:
2004-07-01
2004-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study will evaluate patients who have coronary heart disease to determine if an investigational drug will further lower cholesterol when taken in combination with an approved cholesterol lowering medication.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Ezetimibe
Criteria
Inclusion Criteria:- Patients with elevated cholesterol and coronary heart disease
Exclusion Criteria:
- Patients who do not meet specific cholesterol levels as required by the study